Q4 2024 Becton Dickinson and Co Earnings Call Transcript
Key Points
- Becton Dickinson & Co (BDX) reported strong Q4 results with 7.4% revenue growth and 11.4% increase in adjusted diluted EPS.
- The company achieved 120 basis points of margin expansion and delivered a full-year EPS of $13.14, exceeding initial expectations.
- BDX's med tech and diagnostics businesses grew by 5.9%, demonstrating resilience despite challenges in China.
- The company successfully integrated Advanced Patient Monitoring, contributing $74 million to BD Medical revenue.
- BDX announced its 53rd consecutive year of dividend increases, highlighting its commitment to returning capital to shareholders.
- Fiscal 2024 revenue growth was below initial expectations due to complex market dynamics in China and bioscience pharma.
- The bioscience pharma segment only grew by about 1%, reflecting challenges in market demand.
- BDX anticipates a mid-single-digit decline in China revenues for FY25 due to value-based procurement dynamics.
- The company expects a moderate step back in free cash flow conversion to around 75% due to integration-related investments for APM.
- Higher interest expenses and a higher tax rate, including the impact of Pillar 2, are expected to affect FY25 financials.
Hello, and welcome to BD's fourth-quarter and full year fiscal 2024 earnings call. At the request of BD, today's call is being recorded and will be available for replay on BD's Investor Relations website, investors.bd.com, or by phone at (800) 839-1337 for domestic calls, and area code +1 (402) 220-0489 for international calls. (Operator Instructions)
I will now turn the call over to Greg Rodetis, Senior Vice President, Treasurer and Head of Investor Relations. Please go ahead.
Good morning, and welcome to BD's earnings call. I'm Greg Rodetis, Senior Vice President, Treasurer and Head of Investor Relations. Thank you for joining us. This call is being made available via audio webcast at bd.com. Earlier this morning, BD releases results for the fourth quarter and full year of fiscal 2024. The press release and presentation can be accessed on the IR website at investors.bd.com.
Leading today's call are Tom Polen, BD's Chairman, Chief
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |